Chemcon Speciality Chemicals Ltd
Chemcon Speciality Chemicals Ltd Q1 FY25 Results & Presentation Highlights: Revenue ₹45.5 Cr, EBITDA margin 15.6%
Q1 FY25 investor presentation: what the company reported on revenue, margins and projects.
Based on Chemcon Speciality Chemicals Ltd's Q1 FY25 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.
The short version
Q1 FY25 Revenue from Operations: Rs 45.5 Cr, down 42.6% YoY from Rs 79.3 Cr in Q1 FY24 (Page 7) - Sales Volume (MT) Q1 FY25: - Inorganic Chemicals: 1,181 MT (down from 1,214 MT in Q1 FY24) - Organic Chemicals: 2,416 MT (down from 2,466 MT in Q1 FY24) (Page 6) - Q1 FY25 EBITDA: Rs 7.1 Cr (down 7.8% YoY) (Page 7) - Outlook: - Inorganic chemicals faced challenges including supply chain disruptions, demand softening, and lower realisation with an expected meaningful recovery in the latter half of FY25. Q1 FY25 EBITDA: Rs.
From Chemcon Speciality Chemicals Ltd's Q1 FY25 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- Q1 FY25 Revenue from Operations: Rs 45.5 Cr, down 42.6% YoY from Rs 79.3 Cr in Q1 FY24 (Page 7)
- Sales Volume (MT) Q1 FY25:
- Inorganic Chemicals: 1,181 MT (down from 1,214 MT in Q1 FY24)
- Organic Chemicals: 2,416 MT (down from 2,466 MT in Q1 FY24) (Page 6)
- Q1 FY25 EBITDA: Rs 7.1 Cr (down 7.8% YoY) (Page 7)
- Outlook:
- Inorganic chemicals faced challenges including supply chain disruptions, demand softening, and lower realisation with an expected meaningful recovery in the latter half of FY25.
2 more points management made on revenue & sales performance
Profitability & Margins
See what Chemcon Speciality Chemicals Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Planned capacity expansion with two additional manufacturing units: P-10 and P-11.
- Both new units are designated to manufacture organic chemicals.
- Targeted commissioning timeline: By H2 FY25 (second half of Fiscal Year 2025).
- Current installed capacity (as per Page 18):
- Organic Chemicals (HMDS, CMIC, Bromobenzene and ancillary products): 10,800 MTPA.
- Proposed P-10 and P-11 capacities expected to add to this from H2 FY25.
2 more points management made on capital expenditure plans
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Chemcon Speciality Chemicals Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points management made on order book & pipeline
Chemcon Speciality Chemicals Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹75 Cr, net profit ₹6 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Chemcon Speciality Chemicals Ltd's management said in earlier quarters
- Q3 FY24 earnings call analysis →
- Q2 FY25 earnings call analysis →
- Q4 FY24 earnings call analysis →
- Q3 FY25 earnings call analysis →
- Q2 FY24 earnings call →
- Q3 FY23 earnings call →
- Q2 FY23 earnings call →
- Q4 FY22 earnings call →
- Q3 FY22 earnings call →
- Q2 FY22 earnings call →
- Q1 FY22 earnings call →
- Q4 FY21 earnings call →
Others in Chemicals & Petrochemicals this season
- Himadri Speciality Chemical Ltd (Q1 FY25)
1,199.77 Cr, up 26.17% YoY (vs Rs. Key investor presentation takeaways from Himadri Speciality Chemical Ltd's Q1 FY25 investor presentation — and how it ranks a
- Balaji Amines Ltd (Q1 FY25)
Q1FY25 consolidated revenue from operations: ₹393 crore, down 16% YoY from ₹469 crore in Q1FY24 (Page 5 & 6). Key investor presentation takeaways from Balaji Am
- Linde India Ltd (Q1 FY25)
Revenue for year ended Mar 2024: ₹27,687 million, down 12% vs. Key investor presentation takeaways from Linde India Ltd's Q1 FY25 investor presentation — and ho
- Vidhi Specialty Food Ingredients Ltd (Q1 FY25)
83.0 Crs, up 4.1% year-on-year from Rs. Key investor presentation takeaways from Vidhi Specialty Food Ingredients Ltd's Q1 FY25 investor presentation — and how
Frequently Asked Questions
What were Chemcon Speciality Chemicals Ltd Q1 FY25 results?
Q1 FY25 Revenue from Operations: Rs 45.5 Cr, down 42.6% YoY from Rs 79.3 Cr in Q1 FY24 (Page 7) - Sales Volume (MT) Q1 FY25: - Inorganic Chemicals: 1,181 MT (down from 1,214 MT in Q1 FY24) - Organic Chemicals: 2,416 MT (down from 2,466 MT in Q1 FY24) (Page 6) - Q1 FY25 EBITDA: Rs 7.1 Cr (down 7.8% YoY) (Page 7) - Outlook: - Inorganic chemicals faced challenges including supply chain disruptions, demand softening, and lower realisation with an expected meaningful recovery in the latter half of FY25. Q1 FY25 EBITDA: Rs.
What is Chemcon Speciality Chemicals Ltd share price analysis?
Chemcon Speciality Chemicals Ltd currently shows a neutral. The stock trades at a P/E of 28.1 with a market cap of ₹793 Cr. Investors should review the full earnings analysis for detailed insights.
Is Chemcon Speciality Chemicals Ltd planning capital expenditure?
Planned capacity expansion with two additional manufacturing units: P-10 and P-11.
Keep Chemcon Speciality Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.